Surgical Management and Outcomes of Large High Myopic Macular Holes: Global Macular Hole Multicenter Study 3.
Document Type
Article
Publication Date
5-5-2026
Publication Title
Retina (Philadelphia, Pa.)
Abstract
PURPOSE: To characterize the surgical management and outcomes of large high myopic macular holes (HMMHs).
METHODS: Global multicenter retrospective case series of HMMHs with minimum linear diameter (MLD) ≥ 400 μm undergoing surgery between 2013-2023 with follow up ≥ 3 months. The main outcome measure was the HMMH closure rate at postoperative month 3.
RESULTS: 499 cases of 463 patients from 37 surgeons were included, with mean ± SD age 58.3 ± 12.2 years, 77.0% female, 77.4% primary, 22.6% refractory, and mean ± SD follow-up 18.8 ± 20.2 months. The mean ± SD (range) MLD was 649 ± 280 (400, 2759) µm. Surgery techniques included 127 internal limiting membrane (ILM) peels, 285 ILM flaps, 19 amniotic membrane transplantations (AMT), 36 autologous retinal transplantations (ART), and 32 others. The postoperative month 3 closure rate for all cases was 72.4%. Closure rates significantly decreased with greater CLOSE Study Group size classification for HMMHs treated with ILM peeling or ILM flap (P = 0.006) but not for HMMHs treated with AMT or ART (P > 0.05). Visual acuity (VA) significantly increased from baseline to each follow-up time point among all eyes, with final mean ± SD change in VA of -0.29 (0.55) logMAR (+14.5 ETDRS letters), which did not significantly differ by surgery type.
CONCLUSION: HMMH closure rates are lower than those reported for macular holes in non-highly myopic eyes, but most eyes can still achieve anatomic closure and meaningful VA gains when treated with the appropriate technique.
Recommended Citation
Liu T, Abreu-Arbaje NA, Andoh J, Arevalo JF, Avci R, Bach B, et al [Chau VQ, Sauer L, Williams GA, Mahmoud TH] Surgical management and outcomes of large high myopic macular holes: global macular hole multicenter study 3. Retina. 2026 May 5. doi: 10.1097/IAE.0000000000004871. Epub ahead of print. PMID: 42085031.
DOI
10.1097/IAE.0000000000004871
ISSN
1539-2864
PubMed ID
42085031